相关实验视频

Updated: Jun 24, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

410

对于不可切除的肝细胞癌的下降阶段策略

Georgia Sofia Karachaliou1, Nikolaos Dimitrokallis2, Dimitrios P Moris3

  • 1Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States.

World journal of gastroenterology
|June 10, 2024
PubMed
概括

晚期诊断的肝细胞癌 (HCC) 患者可能从转化疗法和手术中受益. 肝动脉输液化疗显示出降低晚期肝癌的前景,改善生存结果.

关键词:
在下台,下台.肝动脉输液化疗 肝动脉输液化疗肝细胞癌是肝细胞癌.不能切除的肝细胞癌.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.2K

相关概念视频